Real-world use and effectiveness of adjuvant trastuzumab in 2665 consecutive breast cancer patients

被引：0
|
作者：
Tjan-Heijnen, V. C. G.
Seferina, S. C.
Lobbezoo, D. J. A.
Voogd, A. C.
Dercksen, M. W.
van den Berkmortel, F.
van Kampen, R. J. W.
van de Wouw, A. J.
Joore, M. A.
Borm, G. F.
机构：
[1] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Limburg, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Limburg, Netherlands
[3] Maxima Med Ctr, Veldhoven, Brabant, Netherlands
[4] Atrium Med Ctr Parkstad, Heerlen, Limburg, Netherlands
[5] Orbis Med Ctr, Sittard Geleen, Limburg, Netherlands
[6] VieCuri Med Ctr, Venlo, Limburg, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Gelderland, Netherlands
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS-12-P5-21-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-21-04
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Implementation of adjuvant trastuzumab in breast cancer patients in the Netherlands
    de Munck, L.
    Schaapveld, M.
    Siesling, S.
    Otter, R.
    Willemse, P. H. B.
    EJC SUPPLEMENTS, 2010, 8 (03): : 69 - 69
  • [42] Breast cancer patients' quality of life: Real-world data
    Kosmidis, T.
    Athanasakou, B.
    Kosmidis, P. A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
    Syrios, John
    Pappa, Evelina
    Volakakis, Nikolaos
    Grivas, Anastasios
    Alafis, John
    Manioudaki, Sofia
    Tzouda, Vasiliki
    Korogiannos, Athanasios
    Rapti, Cleopatra
    Koufopoulos, Nektarios
    Nikolaidou, Adamantia
    Kanavou, Eleftheria
    Alexopoulos, Athanasios
    Koumarianou, Anna
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2018, 12
  • [44] The cost-effectiveness issue of adjuvant trastuzumab in early breast cancer
    Norum, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (12) : 1617 - 1625
  • [45] Trastuzumab mediated cardiomyopathy in the setting of adjuvant chemotherapy for breast cancer: a real world population based study
    Wadhwa, D.
    Fallah-Rad, N.
    Grenier, D.
    Krahn, M.
    Fang, T.
    Ahmadie, R.
    Lister, D.
    Barac, I.
    Morris, A.
    Jassal, D.
    EUROPEAN HEART JOURNAL, 2008, 29 : 40 - 41
  • [46] Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system
    Cabello, Ana Elisa Ribeiro da Silva
    Cabello, Cesar
    Ramalho, Susana Oliveira Botelho
    Coelho-Filho, Otavio Rizzi
    Machado, Helymar da Costa
    Conde, Delio Marques
    Zeferino, Luiz Carlos
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46 : 1 - 8
  • [47] THE REAL-WORLD COST AND EFFECTIVENESS OF EVEROLIMUS IN METASTATIC BREAST CANCER IN THE CZECH REPUBLIC
    Rihova, B.
    Demlova, R.
    Cerna, R.
    VALUE IN HEALTH, 2018, 21 : S19 - S19
  • [48] Real-world outcomes in patients receiving neo-adjuvant chemotherapy for early-stage breast cancer
    McDonald, Catherine
    Squires, Rebecca
    Gormley, Mark
    Langdon, Ryan
    Archer, Ann
    Ball, Jessica
    Gullick, Georgina
    Caws, Chloe
    Boardman, John
    Mohan, Vivek
    Bahl, Amit
    Jenkins, Jessica
    Comins, Charles
    Gibbs, Lara
    Braybrooke, Jeremy
    Robinson, Timothy
    CANCER RESEARCH, 2021, 81 (04)
  • [49] Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients.
    Olufade, Temitope O.
    Skinner, Karen E.
    Di Santo, Nicola
    Shenolikar, Rahul A.
    Walker, Mark Stephen
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
    Rugo, Hope S.
    Liu, Xianchen
    Li, Benjamin
    McRoy, Lynn
    Chen, Connie
    Layman, Rachel M.
    Brufsky, Adam
    ONCOLOGIST, 2023, 28 (10): : 866 - 874
12345